Cardiovascular Systems is a medical technology company that develops, manufactures, and markets devices to treat vascular diseases. The Company offers peripheral arterial disease products, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides an atherectomy device for the treatment of calcified coronary arteries.

Type
Public
HQ
Saint Paul, US
Founded
1989
Size (employees)
579 (est)
Website
csi360.com
Cardiovascular Systems was founded in 1989 and is headquartered in Saint Paul, US
Report incorrect company information

Key People/Management at Cardiovascular Systems

Scott R. Ward

Scott R. Ward

President and CEO
Jeff Points

Jeff Points

CFO
Rhonda Robb

Rhonda Robb

COO
Laurence L. Betterley

Laurence L. Betterley

VP of Administration
Sandra Sedo

Sandra Sedo

CCO
Ryan Egeland

Ryan Egeland

VP Medical Affairs

Cardiovascular Systems Office Locations

Cardiovascular Systems has offices in Saint Paul and Rochester
Saint Paul, US (HQ)
1225 Old Hwy 8 NW
Rochester, US
651 Campus Drive
Saint Paul, US
651 Campus Drive
Show all (3)
Report incorrect company information

Cardiovascular Systems Financials and Metrics

Cardiovascular Systems Financials

Cardiovascular Systems's revenue was reported to be $178.18 m in FY, 2016 which is a 1.9% decrease from the previous period.
USD

Revenue (Q3, 2018)

157.9 m

Gross profit (Q3, 2018)

129.2 m

Gross profit margin (Q3, 2018), %

81.8%

Net income (Q3, 2018)

(2 m)

EBIT (Q3, 2018)

(1.5 m)

Market capitalization (21-May-2018)

973.1 m

Closing share price (21-May-2018)

29.3

Cash (31-Mar-2018)

109.3 m
Cardiovascular Systems's current market capitalization is $973.1 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

136.6 m181.5 m178.2 m

Revenue growth, %

33%(2%)

Cost of goods sold

31 m39.5 m35.4 m

Gross profit

105.6 m142 m142.8 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Revenue

29.8 m32.3 m34.9 m41.4 m44.7 m47 m43.9 m41.4 m44.5 m49.8 m50 m52.1 m157.9 m

Cost of goods sold

6.9 m7.3 m7.7 m8.9 m9.3 m10.4 m8.8 m8.1 m8.7 m9.5 m9.2 m11.1 m28.7 m

Gross profit

22.9 m25 m27.2 m32.5 m35.4 m36.6 m35.1 m33.3 m35.7 m40.3 m40.9 m41 m129.2 m

Gross profit Margin, %

77%77%78%79%79%78%80%81%80%81%82%79%82%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

126.6 m83.8 m60.6 m

Accounts Receivable

21.4 m30.8 m23.1 m

Inventories

12.9 m14 m17.4 m

Current Assets

162.7 m133.9 m104.9 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Cash

63.2 m146.7 m146 m76.7 m65.3 m62.2 m58.2 m79.3 m103.1 m109.3 m

Accounts Receivable

15.3 m15.9 m19.5 m26.9 m25.8 m23 m24.3 m25.4 m27.9 m31.9 m

Inventories

8.3 m10.3 m11.9 m15.4 m18.2 m18.2 m16.9 m16.2 m16.6 m17 m

Current Assets

88 m174.3 m178.4 m123.4 m112.8 m106.7 m102.1 m122.9 m151.8 m161.2 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(35.3 m)(32.8 m)(56 m)

Depreciation and Amortization

1.2 m2.2 m3.7 m

Inventories

(6.6 m)(1.1 m)(3.5 m)

Accounts Payable

4.6 m581 k(970 k)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q3, 2018

Net Income

(7.3 m)(16 m)(25.7 m)(8.2 m)(13.5 m)(24.2 m)(13.3 m)(28.4 m)(51.1 m)(1.9 m)(815 k)(2.6 m)(2 m)

Depreciation and Amortization

293 k579 k895 k367 k751 k1.3 m887 k1.8 m2.7 m957 k1.9 m2.9 m2.9 m

Inventories

(2 m)(4 m)(5.6 m)(1.8 m)(1.1 m)(329 k)(1.5 m)(4.3 m)(4.3 m)553 k1.3 m835 k(105 k)

Accounts Payable

1.3 m1.4 m4 m2.1 m467 k2.7 m(18 k)(1.1 m)(1.4 m)257 k(1 m)190 k(544 k)
USDY, 2018

Financial Leverage

1.5 x
Show all financial metrics
Report incorrect company information